Brain activation during fear conditioning in humans depends on genetic variations related to functioning of the hypothalamica-pituitarya-adrenal axis: First evidence from two independent subsamples

Psychological Medicine

Volumn 42, Issue 11, 2012, Pages 2325-2335

  Ridder, S ^a   Treutlein, J ^b   Nees, F ^a   Lang, S ^a   Diener, S ^a   Wessa, M ^a   Kroll, A ^a   Pohlack, S ^a   Cacciaglia, R ^a   Gass, P ^b   Schutz G ^c   Schumann, G ^d   Flor, H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Fear conditioning; functional magnetic resonance imaging; genes; hypothalamica pituitarya adrenal axis; PTSD

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; GLUCOCORTICOID RECEPTOR; NR3C1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AMYGDALOID NUCLEUS; CONDITIONED REFLEX; FEAR; FEMALE; FUNCTIONAL NEUROIMAGING; GENETICS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; METABOLISM; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PREFRONTAL CORTEX; REINFORCEMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AMYGDALA; CONDITIONING, CLASSICAL; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; NERVE NET; PITUITARY-ADRENAL SYSTEM; PREFRONTAL CORTEX; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, GLUCOCORTICOID; YOUNG ADULT;

EID: 84870047475     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291712000359     Document Type: Article

References (74)

1. Amano T, Unal CT, Paré D (2010). Synaptic correlates of fear extinction in the amygdala. Nature Neuroscience 13, 489-494
2. Bachmann AW, Sedgley TL, Jackson RV, Gibson JN, Young RM, Torpy DJ (2005). Glucocorticoid receptor polymorphisms and post-traumatic stress disorder. Psychoneuroendocrinology 30, 297-306
3. Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, Bruce AB, Orth DN, Geracioti Jr. TD (1999). Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. American Journal of Psychiatry 156, 585-588
4. Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265
5. Bernstein DP, Fink L (1998). Childhood Trauma Questionnaire: A Retrospective Self-Report Questionnaire and Manual. The Psychological Corporation, San Antonio, TX
6. Blechert J, Michael T, Vriends N, Margraf J, Wilhelm FH (2007). Fear conditioning in posttraumatic stress disorder: evidence for delayed extinction of autonomic, experiential, and behavioural responses. Behavioral Research Therapy 45, 2019-2033
7. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB, Charney DS (1997). Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. American Journal of Psychiatry 154, 624-629
8. Bremner JD, Vermetten E, Schmahl C, Vaccarino V, Vythilingam M, Afzal N, Grillon C, Charney DS (2005). Positron emission tomographic imaging of neural correlates of a fear acquisition and extinction paradigm in women with childhood sexual-abuse-related post-traumatic stress disorder. Psychological Medicine 35, 791-806
9. Büchel C, Morris J, Dolan RJ, Friston KJ (1998). Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron 20, 947-957
10. Cordero MI, Kruyt ND, Merino JJ, Sandi C (2002). Glucocorticoid involvement in memory formation in a rat model for traumatic memory. Stress 5, 73-79
11. Cohen S, Kamarck T, Mermelstein R (1983). A global measure of perceived stress. Journal of Health and Social Behavior 24, 385-396
12. DavisM(1992). The role of the amygdala in fear and anxiety. Annual Review of Neuroscience 15, 353-375
13. de Kloet CS, Vermetten E, Geuze E, Lentjes EG, Heijnen CJ, Stalla GK, Westenberg HG (2008). Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder. Progress in Brain Research 167, 287-291
14. de Kloet ER, Vreugdenhil E, Oitzl MS, JoëlsM(1998). Brain corticosteroid receptor balance in health and disease. Endocrinological Review 19, 269-301
15. Delgado MR, Olsson A, Phelps EA (2006). Extending animal models of fear conditioning to humans. Biological Psychology 73, 39-48
16. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS (1997a). Users Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). American Psychiatric Press: Washington, DC
17. First MB, Spitzer RL, Gibbon M, Williams JBW (1997b). Users Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)-Clinical Version. American Psychiatric Press: Washington, DC
18. Fowles DC, Christie MJ, Edelberg R, Grings WW, Lykken DT, Venables PH (1981). Committee report. Publication recommendations for electrodermal measurements. Psychophysiology 18, 232-239
19. Gilbertson MW, Shenton ME, Ciszewski A, Kasai K, Lasko NB, Orr SP, Pitman RK (2002). Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nature Neuroscience 5, 1242-1247
20. Grabe HJ, Schwahn C, Appel K, Mahler J, Schulz A, Spitzer C, Fenske K, Barnow S, Lucht M, Freyberger HJ, John U, Teumer A, Wallaschofski H, Nauck M, Völzke H (2010). Childhood maltreatment, the corticotropinreleasing hormone receptor gene and adult depression in the general population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 153B, 1483-1493
21. Griesel D, Wessa M, Flor H (2006). Psychometric qualities of the German version of the Posttraumatic Diagnostic Scale (PTDS). Psychological Assessment 18, 262-268
22. Guthrie RM, Bryant RA (2006). Extinction learning before trauma and subsequent posttraumatic stress. Psychosomatic Medicine 68, 307-311
23. Hauer D, Weis F, Papassotiropoulos A, Schmoeckel M, Beiras-Fernandez A, Lieke J, Kaufmann I, Kirchhoff F, Vogeser M, Roozendaal B, Briegel J, de Quervain D, Schelling G (2011). Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy. Critical Care Medicine 39, 643-650
24. Heinz A, Wrase J, Kahnt T, Beck A, Bromand Z, Grü sser SM, Kienast T, Smolka MN, Flor H, Mann K (2007). Brain activation elicited by affectively positive stimuli is associated with a lower risk of relapse in detoxified alcoholic subjects. Alcoholism: Clinical and Experimental Research 31, 1138-1147
25. Herry C, Ferraguti F, Singewald N, Letzkus JJ, Ehrlich I, Lü thi A (2010). Neuronal circuits of fear extinction. European Journal of Neuroscience 31, 599-612
26. Hettema JM, Annas P, Neale MC, Kendler KS, Fredrikson M (2003). A twin study of the genetics of fear conditioning. Archives of Genetic Psychiatry 60, 702-708
27. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH, Lamberts SW (1998). A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. Journal of Clinical Endocrinology and Metabolism 83, 144-151
28. Jaferi A, Bhatnagar S (2007). Corticotropin-releasing hormone receptors in the medial prefrontal cortex regulate hypothalamic-pituitary-adrenal activity and anxietyrelated behavior regardless of prior stress experience. Brain Research 1186, 212-223
29. Jewell CM, Cidlowski JA (2007). Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression. Journal of Clinical Endocrinology and Metabolism 92, 3268-3277
30. Jobling MA, Hurles M, Tyler-Smith C (2003). Human Evolutionary Genetics: Origins, Peoples and Disease. Garland Science: New York
31. Jovanovic T, Ressler KJ (2010). How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. American Journal of Psychiatry 6, 648-662
32. Jovanovic T, Norrholm SD, Blanding NQ, Davis M, Duncan E, Bradley B, Ressler KJ (2010). Impaired fear inhibition is a biomarker of PTSD but not depression. Depression & Anxiety 27, 244-251
33. Keller MC, Miller G (2006). Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best ? Behavioral and Brain Sciences 29, 385-404
34. Kikusui T, Takeuchi Y, Mori Y (2000). Involvement of corticotropin- releasing factor in the retrieval process of fear-conditioned ultrasonic vocalization in rats. Physiology and Behavior 71, 323-328
35. Kohda K, Harada K, Kato K, Hoshino A, Motohashi J, Yamaji T, Morinobu S, Matsuoka N, Kato N (2007). Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: a putative post-traumatic stress disorder model. Neuroscience 148, 22-33
36. Kolber BJ, Roberts MS, Howell MP, Wozniak DF, Sands MS, Muglia LJ (2008). Central amygdala glucocorticoid receptor action promotes fear-associated CRH activation and conditioning. Proceedings of the National Academy of Sciences USA 105, 12004-12009
37. Koper JW, Stolk RP, de Lange P, Huizenga NA, Molijn GJ, Pols HA, Grobbee DE, Karl M, de Jong FH, Brinkmann AO, Lamberts SW (1997). Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Human Genetics 99, 663-668
38. Kumsta R, Entringer S, Koper JW, van Rossum EF, Hellhammer DH, Wü st S (2008). Glucocorticoid receptor gene polymorphisms and glucocorticoid sensitivity of subdermal blood vessels and leukocytes. Biological Psychology 79, 179-184
39. LeDoux JE (2000). Emotion circuits in the brain. Annual Review of Neuroscience 23, 155-184
40. Lonsdorf TB, Weike AI, Nikamo P, Schalling M, Hamm AO, Ohman A (2009). Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder. Psychological Sciences 20, 198-206
41. McFarlane AC, Barton CA, Yehuda R, Wittert G (2011). Cortisol response to acute trauma and risk of posttraumatic stress disorder. Psychoneuroendocrinology 36, 720-727
42. Meyer-Lindenberg A (2010) Intermediate or brainless phenotypes for psychiatric research ? Psychological Medicine 40, 1057-1062
43. Milad MR, Quirk GJ (2002). Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420, 70-74
44. Mü ller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, Kormann MS, Droste SK, Kühn R, Reul JM, Holsboer F, Wurst W (2003). Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nature Neuroscience 6, 1100-1107
45. Nelson EC, Agrawal A, Pergadia ML, Wang JC, Whitfield JB, Saccone FS, Kern J, Grant JD, Schrage AJ, Rice JP, Montgomery GW, Heath AC, Goate AM, Martin NG, Madden PA (2010). H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence. Addiction Biology 15, 1-11
46. Oitzl MS, Fluttert M, Sutanto W, de Kloet ER (1998). Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats. European Journal of Neuroscience 10, 3759-3766
47. Otagiri A, Wakabayashi I, Shibasaki T (2000). Selective corticotropin-releasing factor type 1 receptor antagonist blocks conditioned fear-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats. Journal of Neuroendocrinology 12, 1022-1026
48. Peters J, Kalivas PW, Quirk GJ (2009). Extinction circuits for fear and addiction overlap in prefrontal cortex. Learning and Memory 16, 279-288
49. Pitman RK, Gilbertson MW, Gurvits TV, May FS, Lasko NB, Metzger LJ, Shenton ME, Yehuda R, Orr SP; Harvard/VA PTSD Twin Study Investigators (2006). Clarifying the origin of biological abnormalities in PTSD through the study of identical twins discordant for combat exposure. Annals of the New York Academy of Sciences 1071, 242-254
50. Prokasy WF, Ebel HC (1967). GSR conditioning and sensitization as a function of intertrial interval. Journal of Experimental Psychology 73, 247-256
51. Radloff LS (1977). The CES-D Scale: a self report depression scale for research in the general population. Applied Psychological Measurement 1, 385-401
52. Radulovic J, Rühmann A, Liepold T, Spiess J (1999). Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. Journal of Neuroscience 19, 5016-5025
53. Rauch SL, Shin LM, Phelps EA (2006). Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research-past, present, and future. Biological Psychiatry 15, 376-382
54. Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, Norrholm SD, Kilaru V, Smith AK, Myers AJ, Ramirez M, Engel A, Hammack SE, Toufexis D, Braas KM, Binder EB, May V (2011). Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470, 492-497
55. Rodrigues SM, LeDoux JE, Sapolsky RM (2009). The influence of stress hormones on fear circuitry. Annual Review of Neuroscience 32, 289-313
56. Rohleder N, Joksimovic L, Wolf JM, Kirschbaum C (2004). Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder. Biological Psychiatry 55, 745-751
57. Roozendaal B, McReynolds JR, Van der Zee EA, Lee S, McGaugh JL, McIntyre CK (2009). Glucocorticoid effects on memory consolidation depend on functional interactions between the medial prefrontal cortex and basolateral amygdala. Journal of Neuroscience 29, 14299-14308
58. Rosmond R, Chagnon YC, Chagnon M, Pérusse L, Bouchard C, Björntorp P (2000). A polymorphism of the 5'-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men. Metabolism 49, 1197-1199
59. Shin LM, Liberzon I (2010). The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35, 169-191
60. Spielberger CD, Gorsuch RL, Lushene RE (1970). Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto
61. Stevens A, Ray DW, Zeggini E, John S, Richards HL, Griffiths CE, Donn R (2004). Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. Journal of Clinical Endocrinology and Metabolism 89, 892-897
62. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genetics 19, 162-166
63. Treutlein J, Kissling C, Frank J, Wiemann S, Dong L, Depner M, Saam C, Lascorz J, Soyka M, Preuss UW, Rujescu D, Skowronek MH, Rietschel M, Spanagel R, Heinz A, Laucht M, Mann K, Schumann G (2006). Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Molecular Psychiatry 11, 594-602
64. Tronel S, Alberini CM (2007). Persistent disruption of a traumatic memory by postretrieval inactivation of glucocorticoid receptors in the amygdala. Biological Psychiatry 62, 33-39
65. van Rossum EF, Koper JW, van den Beld AW, Uitterlinden AG, Arp P, Ester W, Janssen JA, Brinkmann AO, de Jong FH, Grobbee DE, Pols HA, Lamberts SW (2003). Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clinical Endocrinology (Oxford) 59, 585-592
66. Wasserman D, Wasserman J, Rozanov V, Sokolowski M (2009). Depression in suicidal males: genetic risk variants in the CRHR1 gene. Genes Brain and Behavior 8, 72-79
67. Wessa M, Rohleder N (2007). Endocrine and inflammatory alterations in posttraumatic stress disorder. Expert Review of Endocrinology and Metabolism 2, 91-122
68. Wigginton JE, Cutler DJ, Abecasis GR (2005). A note on exact tests of Hardy-Weinberg equilibrium. American Journal of Human Genetics 76, 887-893
69. Yang YL, Chao PK, Lu KT (2006). Systemic and intraamygdala administration of glucocorticoid agonist and antagonist modulate extinction of conditioned fear. Neuropsychopharmacology 31, 912-924
70. Yehuda R (2006). Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications. Annals of the New York Academy of Sciences 1071, 137-166
71. Yehuda R, Cai G, Golier JA, Sarapas C, Galea S, Ising M, Rein T, Schmeidler J, Mü ller-Myhsok B, Holsboer F, Buxbaum JD (2009). Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biological Psychiatry 66, 708-711
72. Yehuda R, Flory JD, Pratchett LC, Buxbaum J, Ising M, Holsboer F (2010). Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. Psychopharmacology 212, 405-417
73. Yehuda R, Golier JA, Yang RK, Tischler L (2004). Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biological Psychiatry 55, 1110-1116
74. Yehuda R, LeDoux J (2007). Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron 56, 19-32.